NCT00471393View on ClinicalTrials.gov

Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

April 30, 2007

Conditions
Temporomandibular Degenerative Joint Disease
Interventions
DRUG

1.5% diclofenac in 45.5% DMSO (topical treatment)

DRUG

45.5% DMSO (topical placebo)

Trial Locations (1)

T6G 2N8

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT00471393 - Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease | Biotech Hunter | Biotech Hunter